SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: jim shiau who wrote (2492)5/15/1998 2:33:00 PM
From: Jim Lamb  Read Replies (1) | Respond to of 9523
 
jim,thanks for your time and answer.I thought I had missed something.These estimates are a joke,obviously put out by those that haven't taken 100mg. of Viagra on a empty stomach and waited 20 min. or don't see how much Zithromax is being dispensed in the real world. Jim



To: jim shiau who wrote (2492)5/15/1998 3:41:00 PM
From: zurdo  Read Replies (1) | Respond to of 9523
 
jim, wouldn't the current extraordinary volume of Viagra sales have an effect on a normally slow PFE 2nd quarter? I assume Zacks is not recognizing this possibility for whatever reason. In any case it is to the advantage of long term PFE holders for Zacks and other evaluators to maintain a low 2nd quarter estimate. When the actual earnings are reported it should bode well for PFE stock price appreciation, IMHO. What do you think?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News